Literature DB >> 25978088

Crystal Structures of Polymorphic Prion Protein β1 Peptides Reveal Variable Steric Zipper Conformations.

Lu Yu1, Seung-Joo Lee1, Vivien C Yee1.   

Abstract

The pathogenesis of prion diseases is associated with the conformational conversion of normal, predominantly α-helical prion protein (PrP(C)) into a pathogenic form that is enriched with β-sheets (PrP(Sc)). Several PrP(C) crystal structures have revealed β1-mediated intermolecular sheets, suggesting that the β1 strand may contribute to a possible initiation site for β-sheet-mediated PrP(Sc) propagation. This β1 strand contains the polymorphic residue 129 that influences disease susceptibility and phenotype. To investigate the effect of the residue 129 polymorphism on the conformation of amyloid-like continuous β-sheets formed by β1, crystal structures of β1 peptides containing each of the polymorphic residues were determined. To probe the conformational influence of the peptide construct design, four different lengths of β1 peptides were studied. From the 12 peptides studied, 11 yielded crystal structures ranging in resolution from 0.9 to 1.4 Å. This ensemble of β1 crystal structures reveals conformational differences that are influenced by both the nature of the polymorphic residue and the extent of the peptide construct, indicating that comprehensive studies in which peptide constructs vary are a more rigorous approach to surveying conformational possibilities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25978088     DOI: 10.1021/acs.biochem.5b00425

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.

Authors:  Jamie I Scott; Lorena Mendive-Tapia; Doireann Gordon; Nicole D Barth; Emily J Thompson; Zhiming Cheng; David Taggart; Takanori Kitamura; Alberto Bravo-Blas; Edward W Roberts; Jordi Juarez-Jimenez; Julien Michel; Berber Piet; I Jolanda de Vries; Martijn Verdoes; John Dawson; Neil O Carragher; Richard A O' Connor; Ahsan R Akram; Margaret Frame; Alan Serrels; Marc Vendrell
Journal:  Nat Commun       Date:  2022-05-02       Impact factor: 17.694

2.  Protective V127 prion variant prevents prion disease by interrupting the formation of dimer and fibril from molecular dynamics simulations.

Authors:  Shuangyan Zhou; Danfeng Shi; Xuewei Liu; Huanxiang Liu; Xiaojun Yao
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

3.  Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity.

Authors:  Pascal Krotee; Jose A Rodriguez; Michael R Sawaya; Duilio Cascio; Francis E Reyes; Dan Shi; Johan Hattne; Brent L Nannenga; Marie E Oskarsson; Stephan Philipp; Sarah Griner; Lin Jiang; Charles G Glabe; Gunilla T Westermark; Tamir Gonen; David S Eisenberg
Journal:  Elife       Date:  2017-01-03       Impact factor: 8.140

4.  Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities.

Authors:  Nikolaos Louros; Gabriele Orlando; Matthias De Vleeschouwer; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

5.  Structural evidence for the critical role of the prion protein hydrophobic region in forming an infectious prion.

Authors:  Romany Abskharon; Fei Wang; Alexandre Wohlkonig; Juxin Ruan; Sameh Soror; Gabriele Giachin; Els Pardon; Wenquan Zou; Giuseppe Legname; Jiyan Ma; Jan Steyaert
Journal:  PLoS Pathog       Date:  2019-12-09       Impact factor: 6.823

6.  Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Authors:  Zhen Zheng; Meilan Zhang; Yongheng Wang; Rongsheng Ma; Chenyun Guo; Liubin Feng; Jihui Wu; Hongwei Yao; Donghai Lin
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.